This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Nov;119(5):987-8.

doi: 10.1046/j.1523-1747.2002.19538.x.

Thalidomide neurotoxicity in dermatological patients: the next "STEP"

Anthony Gaspari¹

Affiliations

PMID: 12445181
DOI: 10.1046/j.1523-1747.2002.19538.x

Free article

Review

Thalidomide neurotoxicity in dermatological patients: the next "STEP"

Anthony Gaspari. J Invest Dermatol. 2002 Nov.

Free article

. 2002 Nov;119(5):987-8.

doi: 10.1046/j.1523-1747.2002.19538.x.

Author

Anthony Gaspari¹

Affiliation

¹ Department of Dermatology, University of Maryland School of Medicine, Baltimore, USA.

PMID: 12445181
DOI: 10.1046/j.1523-1747.2002.19538.x

No abstract available

PubMed Disclaimer

Comment on

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.
Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, Duguet C, Djerradine Z, Poli F, Revuz J; Thalidomide Neuropathy Study Group. Bastuji-Garin S, et al. J Invest Dermatol. 2002 Nov;119(5):1020-6. doi: 10.1046/j.1523-1747.2002.19502.x. J Invest Dermatol. 2002. PMID: 12445187 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information